Recent analyses of observational data from 340,000 UK Biobank participants indicate that people with a higher biological age than their same-aged peers have an increased risk of developing cardiometabolic diseases. By contrast, the ability of accelerated biological aging to predict multimorbidity progression is relatively limited.
References
Visseren, F. L. J. et al. Eur. Heart J. 42, 3227–3337 (2021).
Academy of Medical Sciences. Multimorbidity: a Priority for Global Health Research (2018).
Emerging Risk Factors Collaboration. JAMA 314, 52–60 (2015).
Jiang, M. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00438-8 (2024).
Kivimäki, M. et al. Lancet Public Health 2, e277–e285 (2017).
Lopez-Otin, C. et al. Cell 186, 243–278 (2023).
Fraser, H. C. et al. Aging Cell 21, e13524 (2022).
Singh-Manoux, A. et al. PLoS Med. 15, e1002571 (2018).
Rutledge, J., Oh, H. & Wyss-Coray, T. Nat. Rev. Genet. 23, 715–727 (2022).
Williams, S. A. et al. Nat. Med. 25, 1851–1857 (2019).
Oh, H. S. et al. Nature 624, 164–172 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kivimäki, M., Partridge, L. Biological aging as a predictor of cardiometabolic multimorbidity. Nat Cardiovasc Res 3, 256–257 (2024). https://doi.org/10.1038/s44161-024-00444-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-024-00444-w
- Springer Nature Limited